CRISPR gene-editing shows promise in permanently lowering cholesterol and triglycerides
TL;DR
A preliminary study using CRISPR gene editing therapy showed significant reductions in 'bad' cholesterol and triglycerides in patients with heart disease, suggesting potential for one-time treatments to prevent heart attacks, though concerns about safety and ethical considerations remain.
- CRISPR-based treatment cuts cholesterol and triglycerides in early study statnews.com
- Scientists have edited a gene that may reduce high cholesterol permanently CNN
- CRISPR gene-editing works to reduce high cholesterol in a new study NPR
- How a ‘one and done’ gene-editing treatment could lower cholesterol The Washington Post
- First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides www.heart.org
Want the full story? Read the original reporting
Read on statnews.com